NIH Grants $14 Million to Standford to Study Genes and Drug Response

The National Institutes of Health has awarded $14 million in grants to researchers at the Stanford University School of Medicine to fund research into the connection between genes and drug response.
According to an article on GenomeWeb:

The first of these grants is from the National Institute of General Medical Sciences, which has awarded $10 million over four years to Stanford researchers Russ Altman and Teri Klein to expand the PharmGKB knowledgebase, a repository of comprehensive information about how genetics affects drug response in individuals.

Altman and Klein, who is also the director of PharmGKB, created the resource in 2000. They plan to use the grant funds to add in information about drug responses involving multiple genes, and reprogram the knowledgebase so that it can accessed by users with different levels of scientific understanding, among other updates. Currently, the database contains genetic information from nearly 10,000 scientific papers and documents nearly 13,000 associations between specific alleles and drug response phenotypes.

 
Click here to read the entire article on GenomeWeb.